深圳惠泰醫(yi)療器(qi)械(xie)股(gu)份有限公司(si)是(shi)一家專(zhuan)注于(yu)心臟電(dian)生(sheng)理(li)和介入醫(yi)療器(qi)械(xie)的研(yan)發(fa)、生(sheng)產和銷(xiao)售(shou)的高新(xin)技術企業,已形成了以完(wan)整冠(guan)脈(mo)通路和心臟電(dian)生(sheng)理(li)醫(yi)療器(qi)械(xie)為(wei)主導,外(wai)周(zhou)血管和神經介入醫(yi)療器(qi)械(xie)為(wei)重點(dian)發(fa)展方向的業務布(bu)局。于(yu)2021年1月(yue)7日在上海證(zheng)券(quan)(quan)交易所(suo)科創板上市,證(zheng)券(quan)(quan)簡稱“惠泰醫(yi)療”,證(zheng)券(quan)(quan)代碼“688617”。
在電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)器械領(ling)域,公(gong)司是獲(huo)得電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)電(dian)(dian)(dian)(dian)(dian)極導(dao)(dao)管(guan)、可(ke)控(kong)射頻(pin)消融電(dian)(dian)(dian)(dian)(dian)極導(dao)(dao)管(guan)、漂浮(fu)臨(lin)時起(qi)搏(bo)電(dian)(dian)(dian)(dian)(dian)極導(dao)(dao)管(guan)市場(chang)準(zhun)入(ru)并進入(ru)臨(lin)床應(ying)用的(de)國(guo)產(chan)廠(chang)家(jia),打破了(le)國(guo)外產(chan)品(pin)在該領(ling)域的(de)壟(long)斷。公(gong)司電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)電(dian)(dian)(dian)(dian)(dian)極導(dao)(dao)管(guan)和可(ke)控(kong)射頻(pin)消融電(dian)(dian)(dian)(dian)(dian)極導(dao)(dao)管(guan)同時被(bei)科技(ji)部認(ren)(ren)定為國(guo)家(jia)重點新(xin)產(chan)品(pin)、被(bei)深(shen)圳(zhen)(zhen)科工貿信委認(ren)(ren)定為深(shen)圳(zhen)(zhen)市自(zi)主(zhu)(zhu)創新(xin)產(chan)品(pin),可(ke)控(kong)射頻(pin)消融導(dao)(dao)管(guan)被(bei)廣東(dong)省科技(ji)廳認(ren)(ren)定為高新(xin)技(ji)術產(chan)品(pin)。公(gong)司三維(wei)心臟電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)標測(ce)系(xi)統采用國(guo)際主(zhu)(zhu)流磁(ci)電(dian)(dian)(dian)(dian)(dian)融合定位原理(li)(li)(li),創新(xin)性(xing)地(di)將電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)手術中常用的(de)三維(wei)標測(ce)系(xi)統、多道記錄(lu)儀、刺激儀功(gong)能集于(yu)一身(shen),極大地(di)提高了(le)手術效(xiao)率(lv),將心臟電(dian)(dian)(dian)(dian)(dian)生(sheng)(sheng)理(li)(li)(li)標測(ce)系(xi)統的(de)發展推(tui)向了(le)一個(ge)新(xin)高度(du)。
在血(xue)管(guan)介(jie)入器械領域,薄壁鞘(qiao)(血(xue)管(guan)鞘(qiao)組(zu))為(wei)國(guo)(guo)產(chan)獨(du)家產(chan)品,微導(dao)管(guan)(冠(guan)脈應用)和可調閥導(dao)管(guan)鞘(qiao)(導(dao)管(guan)鞘(qiao)組(zu))為(wei)國(guo)(guo)內首個獲(huo)得注冊證的(de)國(guo)(guo)產(chan)同類產(chan)品。錨定(ding)球囊擴張導(dao)管(guan)是國(guo)(guo)內首個導(dao)引(yin)導(dao)管(guan)內采用球囊錨定(ding)方式進(jin)行導(dao)管(guan)交換(huan)的(de)創新(xin)醫(yi)療器械。導(dao)引(yin)導(dao)絲為(wei)國(guo)(guo)產(chan)首個采用復合雙(shuang)芯設計的(de)導(dao)絲,并有多種(zhong)型號(hao)適合各種(zhong)臨床需求(qiu)。
惠泰醫(yi)療高(gao)(gao)度(du)重視研發(fa)人才(cai)的(de)(de)培(pei)(pei)養,通過(guo)(guo)(guo)科學(xue)的(de)(de)人才(cai)培(pei)(pei)養體系和合理的(de)(de)激(ji)勵機制,打造了一個(ge)高(gao)(gao)層次、高(gao)(gao)學(xue)歷(li)、跨學(xue)科,全(quan)面(mian)、穩定且競爭力強(qiang)的(de)(de)研發(fa)團隊。擁有(you)已授權(quan)(quan)的(de)(de)境內(nei)外專利109項(xiang),其中境內(nei)授權(quan)(quan)專利107項(xiang),境外授權(quan)(quan)發(fa)明(ming)專利2項(xiang)。已取得51個(ge)國(guo)內(nei)醫(yi)療器械(xie)(xie)注冊(ce)及(ji)備案(an)證(zheng)書,其中Ⅲ類(lei)醫(yi)療器械(xie)(xie)注冊(ce)證(zheng)47個(ge)。在(zai)國(guo)內(nei)市場(chang),公司(si)心臟(zang)電生理產品覆(fu)蓋醫(yi)院超過(guo)(guo)(guo)800家(jia),血(xue)管介入類(lei)產品覆(fu)蓋醫(yi)院超過(guo)(guo)(guo)3000家(jia)。同(tong)時,公司(si)已取得14個(ge)產品的(de)(de)歐盟CE認證(zheng),在(zai)其他九十多(duo)個(ge)國(guo)家(jia)和地區完(wan)成注冊(ce)和市場(chang)準入。
惠泰醫(yi)療將(jiang)始終致力于自主創(chuang)新和在心腦血管微創(chuang)介入領域的(de)發(fa)展,并將(jiang)為推動全球醫(yi)療事業發(fa)展做出卓越(yue)的(de)貢(gong)獻。